Effectiveness of Topical Treatment of Steroid and Calcineurin Inhibitor Combination Therapy for Atopic Dermatitis in Children at Skopje Hospital, Macedonia
Scientific Journal of Dermatology and Venereology · 2024
DOI: 10.59345/sjdv.v2i1.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Journal of Dermatology and Venereology, 2024. Verfasst von Maria Margareth Wilson.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Atopic dermatitis (AD) is a chronic inflammatory skin disease that often occurs in children. Topical treatments, including steroids and calcineurin inhibitors (CNI), are the main line of AD therapy. This study aimed to evaluate the effectiveness of topical treatment of combination steroid and CNI therapy for AD in children at Skopje Hospital, Macedonia.
Methods
This research was a retrospective study involving 60 children with AD who were treated with combination therapy of steroids and CNIs for 8 weeks. Clinical data, including SCORAD (Severity of Atopic Dermatitis) score and extent of eczema, were collected before and after treatment.
Results
Steroid and CNI combination therapy showed significant improvement in SCORAD score (p
Zitieren
APA
Wilson, M. M. (2024). Effectiveness of Topical Treatment of Steroid and Calcineurin Inhibitor Combination Therapy for Atopic Dermatitis in Children at Skopje Hospital, Macedonia. Scientific Journal of Dermatology and Venereology. https://doi.org/10.59345/sjdv.v2i1.130
Vancouver
Wilson MM. Effectiveness of Topical Treatment of Steroid and Calcineurin Inhibitor Combination Therapy for Atopic Dermatitis in Children at Skopje Hospital, Macedonia. Scientific Journal of Dermatology and Venereology. 2024. doi:10.59345/sjdv.v2i1.130
BibTeX
@article{Wilson2024,
author = {Wilson, Maria Margareth},
title = {Effectiveness of Topical Treatment of Steroid and Calcineurin Inhibitor Combination Therapy for Atopic Dermatitis in Children at Skopje Hospital, Macedonia},
journal = {Scientific Journal of Dermatology and Venereology},
year = {2024},
doi = {10.59345/sjdv.v2i1.130}
}
EUVIMED